REPORT/RECOMMENDATION TO THE BOARD OF SUPERVISORS
OF SAN BERNARDINO COUNTY
AND RECORD OF ACTION
August 5, 2025
FROM
ANDREW GOLDFRACH, ARMC Chief Executive Officer, Arrowhead Regional Medical Center
SUBJECT
Title
Amendment to Agreement with AtriCure, LLC for the Purchase of Specialized Disposal Arterial Fibrillation Products
End
RECOMMENDATION(S)
Recommendation
Approve Amendment No. 1 to Agreement No. 24-918 with AtriCure, LLC, for specialized disposable arterial fibrillation products for sale, updating the product list and related pricing, with no change to the funding allocation of $1,050,000, or the contract term of September 24, 2024 through September 23, 2026.
(Presenter: Andrew Goldfrach, ARMC Chief Executive Officer, 580-6150)
Body
COUNTY AND CHIEF EXECUTIVE OFFICER GOALS & OBJECTIVES
Provide for the Safety, Health and Social Service Needs of County Residents.
FINANCIAL IMPACT
Approval of this item will not result in the use of Discretionary General Funding (Net County Cost). The cost of $1,050,000 is funded by State Medi-Cal, Federal Medicare, private insurances, and other departmental revenue. Funding sources may change in the future pending any legislative activity related to the repeal and/or replacement of the Affordable Care Act. Adequate appropriation and revenue have been included in the Arrowhead Regional Medical Center (ARMC) 2025-26 budget and will be included in the 2026-27 recommended budget.
BACKGROUND INFORMATION
Amendment No. 1 to Agreement No. 24-918 (Agreement) will update the list of specialized disposable arterial fibrillation products available for sale by AtriCure, LLC (AtriCure) and will reduce the prices for some of the existing products ,with no product pricing increases.
On September 24, 2024 (Item No. 14), as the result of a non-competitive procurement, the Board of Supervisors (Board) approved the Agreement with AtriCure for the purchase of proprietary specialized disposal arterial fibrillation products used during open heart surgery, in the not-to-exceed amount of $50,000 for the period of September 24, 2024 through September 23, 2026.
On January 14, 2025 (Item No. 22), the Board approved an increase in funding allocation to the Agreement with AtriCure, in the amount of $1,000,000, to purchase proprietary specialized disposable arterial fibrillation products used during open heart surgery, increasing the total contract amount from the not-to-exceed amount of $50,000 to the not-to-exceed amount of $1,050,000, with no change to the contract term of September 24, 2024 through September 23, 2026.
ARMC recommends approval of the amendment as it will enable the hospital to provide for the safety, health and social services needs of county residents and operate in a fiscally-responsible and business-like manner.
PROCUREMENT
Not applicable.
REVIEW BY OTHERS
This item has been reviewed by County Counsel (Charles Phan, Supervising Deputy County Counsel, 387-5455) on July 2, 2025; ARMC Finance (Chen Wu, Finance and Budget Officer, 580-3165) on July 11, 2025, and County Finance and Administration (Jenny Yang, Administrative Analyst, 387-4884) on July 16, 2025.